Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass.
Moore RG, Khazan N, Coulter MA, Singh R, Miller MC, Sivagnanalingam U, DuBeshter B, Angel C, Liu C, Seto K, Englert D, Meachem P, Kim KK
Obstetrics and gynecology.. 2022 October 1140 (4):631-642. Epub 09/07/2022.
Ember Trial: "Evaluation of multiple protein and molecular biomarkers to estimate risk of cancer in gynecology patients presenting with a pelvic mass"
Moore, R.G.; Miller, M.C.; Kim, K.; Sivagnanalingham, U.; DuBeshter, B.; Angel, C.; Thomas, S.G.; Seto, K.; Englert, D.
2018; 149(Supplement 1): 178-179.
Clinical outcome after adjuvant vaginal brachytherapy for Stage I-II papillary serous clear cell endometrial cancer
Youn, P; Angel, C; DuBeshter, B; Thomas, SG; Moore, RG; Singh, DP; Bylund, KC.
International Journal of Radiation Oncology, Biology, Physics. 2016; 96(2S): E310-E311.
Neoadjuvant chemotherapy and robot-assisted interval cytoreduction in patients with advanced ovarian cancer.
Ackroyd, SA; Altobelli, K; Angel, C; Thomas, SG; DuBeshter, B.
2016; .
Current Role of Robotic Hysterectomy
DuBeshter, Brent MD; Angel, Cynthia, MD; Toy, Eugene, MD; Thomas, Sajeena, MD; Glantz, J. Christopher, MD, MPH.
Journal of Gynecologic Surgery. 2013; 29(4): 174-178.
Experience with computerized chemotherapy order entry
DuBeshter, B.; Walsh, C.J.; Altobelli, K.; Loughner, J.; Angel, C.
Journal Oncology Practice. 2006; 2(2): 49-52.
Chemotherapy dose limits set by users of a computer order entry system
DuBeshter, B.; Griggs, J.; Angel, C.; Loughner, J.
Hospital Pharmacy. 2006; 41(2): 1-7.
Abnormal cervical cytology: a risk factor for endometrial cancer recurrence.
Brown, AK; Gillis, S; Angel,C; Glantz, C; DuBeshter, B.
Int J Gynecological Cancer. 2005; 15: 517-22.
Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans.
Fultz PJ, Jacobs CV, Hall WJ, Gottlieb R, Rubens D, Totterman SM, Meyers S, Angel C, Del Priore G, Warshal DP, Zou KH, Shapiro DE
Radiology.. 1999 August 212 (2):401-10. Epub 1900 01 01.
Can combination vaginal HDR brachytherapy and lymphadenectomy replace adjuvant pelvic XRT for early stage endometrial cancer?
Kang, Y; Chen, Y; Casey, W; Smudzin, T; Rubin, P; Angel, C; DuBeshter, B.
International Journal of Radiation Oncology Biology Physics. 1998; 42(1(1)): 318.
Adjuvant radiotherapy for uterine papillary serous carcinoma: whole abdominopelvic pelvic irradiation.
Casey, W; Chen, Y; DuBeshter, B; Angel, C; Dawson, A; Smudzin, T; Rubin, P.
International Journal of Radiation Oncology, Biology and Physics. 1996; 36(1): 329.
Local therapy for small cell carcinoma of the cervix.
Nakamura, C; Chen, Y; DuBeshter, B; Angel, C; Dawson, A; Casey, W.
International Journal of Radiation Oncology, Biology and Physics. 1996; 36(1(1)): 326.
The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study.
Freeman, S.M.; McCune, C.; Robinson, W.; Abboud, C.N.; Abraham, G.N.; Angel, C.; Marrogi, A.
Hum Gen Ther. 1995; 6(7): 927-939.
Recurrent stage I endometrial adenocarcinoma in the nonirradiated patient: preliminary results of surgical staging.
Angel, C.; DuBeshter, B.; Dawson, A.E.; Keller, J.
Gynecol Oncol. 1993; 2: 221-226.
Morbidity and recurrence with modifications of radical vulvectomy and groin dissection.
Lin, J.Y.; DuBeshter, B.; Angel, C.; Dvoretsky , P.M.
Gynecol Oncol. 1992; 1: 80-86.
Meigs syndrome with elevated serum CA 125.
Lin, J.Y.; Angel, C.; Sickel, J.Z.
Obstet Gynecol. 1992; 3(2): 563-566.
Clinical presentation and management of stage I cervical adenocarcinoma: a 25 year experience.
Angel, C.; DuBeshter, B.; Lin, J.Y.
Gynecol Oncol. 1992; 1(44): 71-80.
Comparison of transabdominal and endovaginal sonographic approaches in the diagnosis of a case of cervical pregnancy successfully treated with methotrexate.
Sherer, D.M.; Abramowicz, J.S.; Thompson, H.O.; Liberto, L.; Angel, C.; Woods, J.R. Jr.
J Ultrasound Med. 1991; 7(10): 409-411.
Endometrial carcinoma: the relevance of cervical cytology.
DuBeshter, B.; Warshal, D.P.; Angel, C.; Dvoretsky, P.M.; Lin, J.Y.; Raubertas, R.F.
Obstet Gynecol. 1991; 3(77): 458-462.
"Endometrial Carcinoma: The Relevance of Cervical Cytology".
DuBeshter, B; Warshal, D.P.; Angel, C; Dvoretsky, P.M.; Lin, J; Yandraubertas, R.F..
Proc Soc Gynecologic Oncology. 1991; .
Survival time. Causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer.
Dvoretsky, P.M.; Richards, K.A.; Angel, C.; Rabinowitz, L.; Beecham, J.B.; Bonfiglio, T.A.
Hum Pathol. 1988; 11(19): 1273-1279.
Distribution of disease at autopsy in 100 women with ovarian cancer.
Dvoretsky, P.M.; Richards, K.A.; Angel, C.; Rabinowitz, L.; Stoler, M.H.; Beecham, J.B.; Bonfiglio, T.A.
Hum Pathol. 1988; 1(19): 57-63.
Stage IB cervical carcinoma: a comparison of clinical, MR, and pathologic staging.
Rubens, D.; Thornbury, J.R.; Angel, C.; Stoler, M.H.; Weiss, S.L.; Lerner, R.M.; Beecham, J.
AJR Am J Roentgenol. 1988; 1(19): 57-63.
Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.
Slayton, R.D.; Blessing, J.A.; Angel, C.; Berman, M.
Cancer Treat Rep. 1988; 1(150): 135-138.
Magnetic resonance imaging and the pathologic correlation in stage IB cervix cancers.
Angel, C.; Beecham, J.B.; Rubens, D.J.; Thornbury, J.R.; Stoler, M.H.
Gynecol Oncol. 1987; 12(71): 303-304.